about
Implementing criteria-based early switch/early discharge programmes: a European perspectivePathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infectionsCost of treatment in a US commercially insured, HIV-1-infected populationExacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis.Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon.Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia.Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in EuropeComparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey.Health utilities using the EQ-5D in studies of cancer.Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis.Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis.Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia.Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population.Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.The impact of parenteral nutrition preparation on bloodstream infection risk and costs.Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates.A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization.Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype.Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia.Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.Early Switch/Early Discharge Opportunities for Hospitalized Patients with Methicillin-Resistant Staphylococcus Aureus Complicated Skin And Soft Tissue Infections: Proof Of Concept in the United Arab Emirates.Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE).Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.Statistical implications of utility weighted and equally weighted HRQL measures: an empirical study.Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.Impact of acute bleeding on daily activities of patients with congenital hemophilia with inhibitors and their caregivers and families: observations from the Dosing Observational Study in Hemophilia (DOSE).Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A.Effect of acute bleeding on daily quality of life assessments in patients with congenital hemophilia with inhibitors and their families: observations from the dosing observational study in hemophilia.Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patients.Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis.Disease-specific patient reported outcome tools for systemic lupus erythematosus.A brief assessment tool for body image in systemic lupus erythematosus.Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
P50
Q26801251-182C564A-9F01-4217-9BB5-177BE441E32CQ26801257-1CE166BE-F335-474B-A08F-FCD98CDA707DQ28539139-41243207-8304-490B-8743-9F0EBAED4BC4Q30617111-FD48A6E1-0BDC-4BD1-ABE9-3E1D690E9B89Q31141332-3E7D9E73-1D69-43E7-AE9F-2259C5C9804FQ31162323-D1FF8E4A-CF21-4E21-ADB0-BCD869661A6FQ33864978-B1494CDE-865F-40D3-A501-97220F526AA3Q34185105-46A453B5-24D6-43E3-8919-68EEB0065854Q34273682-8D33E7E5-BBA4-4C90-90BB-62D2C653B68AQ36815058-00836F12-9B6C-4636-8E0E-B897CC97F9F8Q36820376-5F0B4A1B-1097-42A5-AECD-D947E3BC77C1Q37396561-1D4EEC6C-28D1-43F9-BFB1-6B7A7E3E9D71Q37514635-4D32C70D-EA95-4108-8273-F31A531A341EQ37632087-AB3461C5-8B39-48C5-B5CE-9550B76A7533Q38075579-10D233F1-8FAF-4977-97F5-BD309C081B1CQ38196285-BD795E59-AE28-48FD-A456-7BD8244EF6A1Q38199330-36CA3B5C-31D8-4FB6-8032-38CBFD169E15Q38199805-F15C78BA-64CC-4644-B317-8E625BC9D624Q38220130-6311ED11-74A8-4BD8-A301-5743379350BCQ38540488-E6C76C6F-3DAA-4E87-8D73-C3D4884FE791Q38545293-E9F1C843-3265-469C-82A8-2E4C28B5A912Q38551674-FA9E76AF-3048-43AB-9826-DE8D1912BBB0Q38553334-4026BF97-EBBB-46FF-8AC3-8F3FAE801530Q38719598-E9AAA600-57F6-4664-A58A-6FAA7BD6B297Q38795368-4905BF67-EABB-48CC-9E54-B6664ECBD721Q39211783-C9A2326C-EA61-4074-9A09-4935658BC2AAQ39750098-3A8EF573-D80D-4A66-B4ED-54C1DB5F2264Q41203504-BE6DFA47-B52A-4792-A43E-F4514FF3EF3CQ43295114-31A12863-788D-4D8B-A719-E3064E414E81Q44255382-C8F8629B-6FEB-4EE2-B2AB-19E532E59BFCQ44898891-B58949E4-66DB-4A88-B8F3-A0967D6A1BC7Q45055826-4A9C1509-149F-4182-A9FB-D51BD294B441Q45868687-9A842B61-89E1-4227-9206-57766FDD46CCQ45868859-CC29AAB4-9F94-4845-8FBB-E976C49F64CDQ45881996-3F74843B-E217-4882-80AD-3C45EA4CF66AQ46202455-4F6E975A-DD9B-418F-9812-FF43D3B1E69AQ48082382-447B4B72-B926-4016-BBA8-CAEF1F87BFB1Q48458464-001C7B85-7823-4C00-A39B-7BFE101C6ABBQ48523437-33CA0BCC-F455-4770-881E-996DB90E673CQ51870512-10E94CD1-5F39-43B6-B8DE-2C9A08D3D900
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Caitlyn Solem
@ast
Caitlyn Solem
@en
Caitlyn Solem
@es
Caitlyn Solem
@nl
Caitlyn Solem
@sl
type
label
Caitlyn Solem
@ast
Caitlyn Solem
@en
Caitlyn Solem
@es
Caitlyn Solem
@nl
Caitlyn Solem
@sl
altLabel
Caitlyn Wilke
@en
prefLabel
Caitlyn Solem
@ast
Caitlyn Solem
@en
Caitlyn Solem
@es
Caitlyn Solem
@nl
Caitlyn Solem
@sl
P106
P21
P31
P496
0000-0002-4914-8052